GDRX Goodrx Holdings Inc

P/E 71.4
Forward P/E 10.29
Price/Sales 1.551
Beta 1.693
Div Yield --
Market Cap --

Company Analysis

Latest News

🟒 Goodrx is trading 5% up in pre-market

Goodrx is trading at $3.72 (+5.06%), with no clear catalyst identified for its October 26 pre-market gain. - The price is versus the $3.54 October 23 close. -...

🟒 Goodrx is trading 9.17% up in pre-market on October 15, 2026 amid healthcare sector gains

Goodrx is trading at $3.69, up 9.17% in pre-market, with the healthcare sector’s 1.45% gain offering the clearest context amid defensive rotation tied to...

πŸ”΄ Goodrx is trading 6.59% down today in after-hours trading amid broader risk-off conditions

Goodrx is trading 6.59% down at $3.26 in after-hours trading, with the decline appearing primarily linked to broader risk-off conditions. - It closed at $3.49...

πŸ”΄ Goodrx is trading 8.4% down today in pre-market with no confirmed company-specific catalyst

Goodrx is trading 8.4% down at $3.26 after a sharp reversal from the September 14 close, with the decline appearing related to pre-market trading. - No new...

🟒 Goodrx is trading 5% up today as healthcare stocks attract defensive buying

Goodrx is trading 5.16% up at $3.56, outperforming a broadly weaker market as healthcare stocks attract defensive buying. - Healthcare ETF XLV is up 1.28%...

πŸ”΄ Goodrx is trading 5% down today after healthcare stocks sell off

Goodrx is trading 5% down at $3.34, primarily as healthcare stocks sell off amid concerns over insurance coverage, subsidy expirations, and rising industry...

GoodRx Backer Francisco Partners Sells $5.4M in Stock, No Trading Plan

GoodRx Backer Francisco Partners Sells $5.4M in Stock, No Trading Plan

Francisco Partners offloaded approximately $5.48 million of GoodRx Class A shares in late August. The major shareholder sold over 1.29 million shares on...

🟒 Goodrx is trading 9.68% up in pre-market with no clearly reported company-specific catalyst

Goodrx is trading at $3.85, +9.68% in pre-market, with no clearly reported company-specific catalyst explaining the August 28, 2026 gain. - Latest earnings,...

πŸ”΄ Goodrx is trading 5.3% down today with no clear catalyst identified

Goodrx is trading 5.3% down at $3.60, with no clear company-specific catalyst identified for the August 12, 2026 decline. - No company-specific announcement,...

🟒 Goodrx is trading 5.6% up today after raising 2026 guidance

Goodrx is trading 5.6% up now at $3.87 after investors continued responding to August 5 second-quarter results and raised 2026 guidance. - Revenue reached...

GoodRx Pops 7% Ahead of Earnings, but Can a $3 Stock Convince Investors the Turnaround Is Real?

GoodRx Pops 7% Ahead of Earnings, but Can a $3 Stock Convince Investors the Turnaround Is Real?

Shares of GoodRx surged 7.1% to $3.38 on August 7 as investors positioned ahead of the company's Q2 2026 earnings report, riding a broad risk-on session that...

🟒 Goodrx is trading 11% up today after Q2 revenue beat and higher 2026 guidance

Goodrx is trading 11.16% up now at $3.63 after its August 5, 2026 second-quarter results and August 6 conference call, with a revenue beat and raised...

🟒 Goodrx is trading 6.4% up today after Q2 revenue beat and raised 2026 guidance

Goodrx is trading 6.4% up now at $3.48 after its August 5, 2026, second-quarter results beat revenue expectations and management raised full-year 2026 revenue...

🟒 Goodrx is trading 7.3% up today after raising its full-year 2026 guidance

Goodrx is trading 7.3% up at $3.51 after its Q2 earnings report showed stronger-than-expected revenue and an upward revision to its full-year 2026 revenue and...

🟒 Goodrx is trading 6.7% up today after beating revenue estimates and raising 2026 guidance

Goodrx is trading 6.7% up at $3.49 in after-hours trading following its second-quarter 2026 earnings release and raised full-year guidance. β€’ Revenue of $200.4...

🟒 Goodrx is trading 7.1% up today ahead of Q2 earnings and a broad market rally

Goodrx is trading 7.1% up at $3.38 as investors position ahead of its Q2 2026 earnings report on August 05, 2026. β€’ The move comes during a strong risk-on...

Goodrx Holdings Inc Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026

Goodrx Holdings Inc is expected to report Q2 2026 revenue of $193.23 million and an earnings per share of $0.04, while the current stock price of $3.12 remains...

🟒 Goodrx is trading 5.2% up today amid broader risk-on market rally

Goodrx is trading 5.2% up at $3.23 today, rising alongside a strong risk-on move in U.S. equities. β€’ The gain appears driven by improving market sentiment...

πŸ”΄ Goodrx is trading 5.9% down today as healthcare sector drops on managed care margin concerns

Goodrx is trading 5.9% down today at $3.03 as the broader healthcare sector faces selling pressure. β€’ The healthcare sector is down over 2% today, driven by...

🟒 Goodrx is trading 5.6% up today, extending a multi-day rebound amid a broader healthcare sector rally

Goodrx is trading 5.6% higher at $3.29, extending a multi-day rebound from last week’s lows despite a lack of company-specific news. β€’ The move appears driven...